Clinical data | |
---|---|
Pronunciation | /bjuːˈpɪvəkeɪn/ |
Trade names | Marcaine, Sensorcaine, Posimir, others |
AHFS/Drugs.com | Monograph |
License data |
|
Pregnancy category |
|
Routes of administration | Parenteral, topical, implant |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | n/a |
Protein binding | 95% |
Metabolism | Liver |
Onset of action | Within 15 min[5] |
Elimination half-life | 3.1 hours (adults)[5] 8.1 hours (neonates)[5] |
Duration of action | 2 to 8 hr[6] |
Excretion | Kidney, 4–10% |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII |
|
KEGG | |
ChEBI |
|
ChEMBL |
|
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.048.993 |
Chemical and physical data | |
Formula | C18H28N2O |
Molar mass | 288.435 g·mol−1 |
3D model (JSmol) | |
Melting point | 107 to 108 °C (225 to 226 °F) |
| |
| |
(what is this?) (verify) |
Bupivacaine, marketed under the brand name Marcaine among others, is a medication used to decrease sensation in a specific small area.[5] In nerve blocks, it is injected around a nerve that supplies the area, or into the spinal canal's epidural space.[5] It is available mixed with a small amount of epinephrine to increase the duration of its action.[5] It typically begins working within 15 minutes and lasts for 2 to 8 hours.[5][6]
Possible side effects include sleepiness, muscle twitching, ringing in the ears, changes in vision, low blood pressure, and an irregular heart rate.[5] Concerns exist that injecting it into a joint can cause problems with the cartilage.[5] Concentrated bupivacaine is not recommended for epidural freezing.[5] Epidural freezing may also increase the length of labor.[5] It is a local anaesthetic of the amide group.[5]
Bupivacaine was discovered in 1957.[7] It is on the World Health Organization's List of Essential Medicines.[8] Bupivacaine is available as a generic medication.[5][9] An implantable formulation of bupivacaine (Xaracoll) was approved for medical use in the United States in August 2020.[10][11][12]
FDA Xaracoll approval letter
was invoked but never defined (see the help page).Innocoll PR
was invoked but never defined (see the help page).